fda and tirzepatide Medscape | The approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after FDA approves Eli Lilly's diabetes

Do not go lower without medical supervision

On a U100 scale, 1 mL is labelled as 100 units

Prioritize Hydration GLP-1 medications can sometimes decrease your thirst cues along with your hunger cues

For patients who meet candidacy criteria, the medication is one element of a protocol that also addresses hormonal status, nutrition architecture, and critically the off-ramp plan that determines whether results are maintained after the medication is eventually tapered

It prompts the pancreas to release insulin by mimicking a hormone called GLP-1, or glucagon-like peptide 1

Choosing the right approach often means looking beyond quick fixes and considering long-term well-being